BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2014
View Archived Issues
Novel association found for intracranial aneurysm susceptibility
Read More
Cardioxyl Pharmaceuticals begins first trial of CXL-1427
Read More
Roche discloses novel protein ligase inhibitors for cancer
Read More
Daiichi Sankyo discloses new agents for bacterial infections
Read More
Novel thrombin inhibitors prepared at Merck & Co.
Read More
Emory University patents new NMDA receptor modulators
Read More
Amgen divulges novel TRPM8 antagonists for migraine
Read More
Long-term analysis of a prognostic gene signature for breast cancer
Read More
NICE publishes final guidance recommending Eylea in England
Read More
Known cognition enhancer active in models of neuropathic pain
Read More
Application for approval of an oral disintegrating tablet formulation
Read More
Critical Outcome Technologies signs letter of intent with Portage Biotech for COTI-2
Read More
Treatment under way in phase IIb study of brilacidin for ABSSSI
Read More
Orexigen Therapeutics receives European CHMP questions on NB-32 MAA
Read More
Bexsero available in Canada
Read More
NICE final guidance recommends Pixuvri for relapsed/refractory B-cell NHL
Read More
Phase I study of tuberculosis vaccine DAR-901 opens
Read More
Dosing completed in phase II trial of Zoenasa for ulcerative colitis
Read More
Multifunctional polynitroxylated albumin for the early treatment of stroke
Read More
Chinese researchers synthesize new PI3Kdelta inhibitors
Read More
CytoVac initiates phase II study of ALECSAT for glioblastoma multiforme
Read More
InDex Pharmaceuticals closes new rights issue
Read More
NeRRe Therapeutics initiates phase II study of orvepitant for EGFR inhibitor-induced pruritus
Read More
Mast Therapeutics opens international enrollment in EPIC study of MST-188
Read More
Adocia reports preliminary results from phase I/II trial of BioChaperone Combo
Read More